EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Autologous bone marrow mononuclear cell administration in a large cohort of 1,011 patients with autism spectrum disorder: a retrospective observational study

Alok Sharma iD, Nandini Gokulchandran iD, Hemangi Sane iD, Pooja Kulkarni iD, Krishnaveni Kannan iD, Zubiya Shaikh iD, Hema Biju iD, Amruta Paranjape iD, Myola D'sa iD, Prerna Badhe iD

Clinical Transplantation and Research · 31.03.2026 · 40 (1) · 116-128

DOI: 10.4285/ctr.25.0009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation and Research, online erschienen am 18.12.2025. Verfasst von Alok Sharma und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Services, NeuroGen Brain and Spine Institute, Navi Mumbai, India. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This retrospective observational study analyzed the therapeutic efficacy of autologous bone marrow mononuclear cells (BMMNCs) in a large cohort of patients with autism spectrum disorder (ASD).

Methods

Overall, 1,011 patients with ASD who received intrathecal administration of autologous BMMNCs were included. Changes in symptoms and outcome measures-the Indian Scale of Autism Assessment (ISAA) and Childhood Autism Rating Scale (CARS)-were recorded. Brain positron emission tomography computed tomography (PET/CT) was used to objectively assess changes in brain metabolism.

Results

At a mean follow-up of 19.3 months, 90.6% of patients showed improvement after cell therapy. Symptomatic improvements were observed in attention and concentration, command following, eye contact, sitting tolerance, social interaction, hyperactivity, communication, speech, stereotypical behavior, aggressiveness, and self-injurious behavior. Patients who received multiple doses of cell therapy demonstrated better outcomes, and improvements were seen across all age groups and regardless of disease severity. Changes in ISAA and CARS scores were statistically significant (P

Schlagwörter

Stichwörter der Autor:innen

Autism spectrum disorderBone marrowCell therapyMononuclear cellsPositron emission tomography computed tomography

Autor:innen und Institutionen

  • Department of Medical Services, NeuroGen Brain and Spine Institute, Navi Mumbai, India.
  • Department of Research and Development, NeuroGen Brain and Spine Institute, Navi Mumbai, India.
  • Department of Neurorehabilitation, NeuroGen Brain and Spine Institute, Navi Mumbai, India.
  • Department of Regenerative Laboratory, NeuroGen Brain and Spine Institute, Navi Mumbai, India.

ORCID-Profile: Alok Sharma, Nandini Gokulchandran, Hemangi Sane, Pooja Kulkarni, Krishnaveni Kannan, Zubiya Shaikh, Hema Biju, Amruta Paranjape, Myola D'sa, Prerna Badhe

Zitieren

APA

Sharma, A., Gokulchandran, N., Sane, H., Kulkarni, P., Kannan, K., Shaikh, Z., Biju, H., Paranjape, A., D'sa, M., & Badhe, P. (2026). Autologous bone marrow mononuclear cell administration in a large cohort of 1,011 patients with autism spectrum disorder: a retrospective observational study. Clinical Transplantation and Research, 40(1), 116-128. https://doi.org/10.4285/ctr.25.0009

Vancouver

Sharma A, Gokulchandran N, Sane H, Kulkarni P, Kannan K, Shaikh Z, et al. Autologous bone marrow mononuclear cell administration in a large cohort of 1,011 patients with autism spectrum disorder: a retrospective observational study. Clinical Transplantation and Research. 2026;40(1):116-128. doi:10.4285/ctr.25.0009

BibTeX
@article{Sharma2026,
  author = {Sharma, Alok and Gokulchandran, Nandini and Sane, Hemangi and Kulkarni, Pooja and Kannan, Krishnaveni and Shaikh, Zubiya and Biju, Hema and Paranjape, Amruta and D'sa, Myola and Badhe, Prerna},
  title = {Autologous bone marrow mononuclear cell administration in a large cohort of 1,011 patients with autism spectrum disorder: a retrospective observational study},
  journal = {Clinical Transplantation and Research},
  year = {2026},
  volume = {40},
  number = {1},
  pages = {116--128},
  doi = {10.4285/ctr.25.0009}
}
Kostenlos starten →